Gabapentin Tablet, Film Coated
Product Images NDC 70518-2098

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-2098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin 600mg 70518 2098 01

Gabapentin 600mg 70518 2098 01
Gabapentin is a prescription medication available in tablet form. The National Drug Code is 70518-2098-01, and the batch number and expiration date are not provided. The medication is manufactured by ACI Healthcare USA, Inc., Coral Springs, FL, and the quantity of medication included is 180 tablets. It must be kept out of reach of children. There are no specific instructions for dosage or usage; customers should refer to the package insert. It should be stored at room temperature between 63 and 77 degrees Fahrenheit (15-30 degrees Celsius), with allowable deviations up to 59-86 degrees Fahrenheit (15-30 degrees Celsius), as per the United States Pharmacopeia standards. This medication can only be obtained with a prescription from a licensed doctor.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Gabapentin is a medication available as 600 mg tablets in a bottle with 30 quantity. It is manufactured by ACI Healthcare USA, Inc. and its National Drug Code (NDC) is 70518-2098-00. The expiration date and lot number are not available. It should be kept out of children's reach and stored at room temperature. The package insert should be consulted for directions for use. This medicine requires a prescription and has been repackaged by RemedyRepack Inc.*
FDA Label Image

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)

Figure 1 (Ab1e0185 B802 4cf2 A5d4 B71f27f1dcb0 00)
This is a formula to calculate the estimated creatinine clearance (CLOr) for patients based on their age, weight, and serum creatinine level. The formula is adjusted for female patients by multiplying the result by 0.85.*
FDA Label Image

Chem Structure (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)

FDA Label Image

Figure01 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)

FDA Label Image

Figure02 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)

FDA Label Image

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)

Figure03 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
The text describes a graph showing the proportion of patients who responded to treatment in controlled studies for PHN. Two studies are compared, with the percentage of responders shown for each. There are also three lines containing numbers, which appear to represent study groups and their associated costs.*
FDA Label Image

Figure4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.